SCHEMBL25205773

SCHEMBL25205773

O=C(NC[C@H]1CNCCO1)c1csc(-c2cnn(-c3ccccc3)c2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.49
TAAR1 Q96RJ0 2/20 0.49
SLC6A3 Q01959 1/20 0.49
CHEK1 O14757 1/20 0.44
NTRK1 P04629 2/20 0.43
USP30 Q70CQ3 1/20 0.42
ALDH1A1 P00352 1/20 0.41
HPGDS O60760 1/20 0.41
HPGD P15428 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ACKR3 P25106 1/20 0.39
NPC1 O15118 2/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25230295 1.00 KCNH2 (0.49) KCNH2TAAR1SLC6A3CHEK1NTRK1
SCHEMBL25211163 1.00 KCNH2 (0.49) KCNH2TAAR1SLC6A3CHEK1NTRK1
SCHEMBL25238874 0.85 USP30 (0.49) KCNH2TAAR1SLC6A3CHEK1NTRK1
SCHEMBL25237287 0.85 USP30 (0.49) KCNH2TAAR1SLC6A3CHEK1NTRK1
SCHEMBL25230167 0.85 USP30 (0.49) KCNH2TAAR1SLC6A3CHEK1NTRK1
SCHEMBL25233639 0.83 USP30 (0.51) CHEK1NTRK1USP30HPGDCYP1A2
SCHEMBL25245499 0.80 KHK (0.45) KCNH2TAAR1SLC6A3CHEK1HPGDS
SCHEMBL25243775 0.79 USP30 (0.52) USP30HPGDSHPGDCYP1A2CYP3A4
SCHEMBL25217767 0.79 MAPK8 (0.47) KCNH2TAAR1SLC6A3CHEK1NTRK1
SCHEMBL25253372 0.79 MAPK8 (0.47) KCNH2TAAR1SLC6A3CHEK1NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250049776-A1 AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A SYSTEMIC TREATMENT OF DISEASES AND CONDITIONS INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM) (FR) 2025-02-13 US disclosed
EP-4183449-A1 AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF Samsara Therapeutics Inc. (US) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250049776-A1 AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A SYSTEMIC TREATMENT OF DISEASES AND CONDITIONS BECN1, TFEB, SQSTM1 KCNH2 4865/4885TAAR1 3846/4885SLC6A3 792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.